SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-012053
Filing Date
2023-04-13
Accepted
2023-04-13 06:05:09
Documents
12
Period of Report
2023-04-13
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 35824
  Complete submission text file 0001493152-23-012053.txt   215119

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE glsi-20230413.xsd EX-101.SCH 3266
3 XBRL LABEL FILE glsi-20230413_lab.xml EX-101.LAB 34916
4 XBRL PRESENTATION FILE glsi-20230413_pre.xml EX-101.PRE 22815
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3876
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

IRS No.: 205473709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39555 | Film No.: 23816959
SIC: 2834 Pharmaceutical Preparations